Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Serial FCA Relator Scores Yet Another Massive PPP Loan Settlement

Aug 14, 2025 | False Claims Act, federal investigations

The federal False Claims Act (FCA) allows private whistleblowers (known as “Relators”) who have knowledge of FCA violations to file lawsuits on behalf of the government and, in exchange, receive between 15% and 30% of the government’s eventual...

False Claims Act Risks for Healthcare Private Equity Investors

Aug 14, 2025 | False Claims Act, federal investigations, Health Care, Health Care Fraud, Healthcare Transactions

The federal False Claims Act (FCA) represents one of – if not the – top regulatory and liability risk that healthcare providers face when doing business with federal healthcare programs (FHPs) including Medicare and Medicaid. The FCA prohibits, among other things,...

Voluntary Disclosure of Unpaid Customs Duties Results in $6.8 Million False Claims Act Settlement

Jul 24, 2025 | False Claims Act, federal investigations, Fraud Investigations

In yet another False Claims Act (FCA) settlement involving avoidance of customs duties, on July 23, 2025, the Department of Justice (DOJ) announced that New Hampshire-based Global Plastics and Marco Polo International — both subsidiaries of MGI International...

DOJ Alleges Customs Fraud in New False Claims Act Lawsuit

Jul 22, 2025 | False Claims Act, federal investigations, Fraud Investigations

On July 15, the United States Attorney’s Office for the District of South Carolina announced that it had intervened in a case brought under the False Claims Act (FCA)’s qui tam (whistleblower) provisions. The lawsuit was filed against Global Office...

Can Breaching a Contract With the Government Result in False Claims Act Liability? It Depends…

Jul 17, 2025 | False Claims Act, federal investigations, Government Investigations, Health Care, Health Care Fraud

The False Claims Act (FCA) is the government’s most powerful civil tool to investigate and pursue claims against businesses and individuals who submit false or fraudulent claims to the government. Every year, the Department of Justice (DOJ) obtains billions of dollars...

Medicare Audits: How Long Does Medicare Have to Reopen Claims?

Jul 2, 2025 | Commercial Payor Audits, federal investigations, Health Care, Health Care Fraud, Medicare and Medicaid

The attorneys at Chilivis Grubman represent a wide variety of healthcare providers and suppliers in connection with Medicare audits and overpayment appeals. Clients often ask us how long a CMS contractor has to reopen a claim for purposes of conducting a post-payment...
« Older Entries

Recent Posts

  • Florida Attorney General Files False Claims Act Lawsuit Against Textbook Publishers
  • State False Claims Acts and Their Role in Fraud Enforcement
  • Serial FCA Relator Scores Yet Another Massive PPP Loan Settlement
  • False Claims Act Risks for Healthcare Private Equity Investors
  • Land Use Win for Little Five Points: Findley Plaza Redesign Breaks Ground

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group